Clinical Trials Browser

Hodgkin Disease × Immune Checkpoint Inhibitors × Lymphoid × Clear all

NCT05137886 2021-12-17

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Phase 2 Unknown

Hodgkin Disease, Recurrence

NCT04419441 2020-09-16

ICI-RT-1

Hodgkin Disease